Skip to main content

letter

. 1990 May 26;300(6736):1399. doi: 10.1136/bmj.300.6736.1399

Enalapril and metoprolol in diabetic nephropathy.

PMCID: PMC1662956 PMID: 2372593

1399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Björck S., Mulec H., Johnsen S. A., Nyberg G., Aurell M. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. BMJ. 1990 Apr 7;300(6729):904–907. doi: 10.1136/bmj.300.6729.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
Inman W. H., Rawson N. S., Wilton L. V., Pearce G. L., Speirs C. J. Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. BMJ. 1988 Oct 1;297(6652):826–829. doi: 10.1136/bmj.297.6652.826. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sawicki P. T., Mühlhauser I., Baba T., Berger M. Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus? Diabetologia. 1990 Feb;33(2):121–124. doi: 10.1007/BF00401052. [DOI] [PubMed] [Google Scholar]
Speirs C. J., Dollery C. T., Inman W. H., Rawson N. S., Wilton L. V. Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure. BMJ. 1988 Oct 1;297(6652):830–832. doi: 10.1136/bmj.297.6652.830. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES